Consultations

Search consultations and choose filters to show only the results you want

Consultation topic

Publication date

390 consultations

Equality and Human Rights Consultation - NICE NG 103 - Flu Vaccination: Increasing Uptake

Published 22 August 2018Closed

Equality and Human Rights Consultation - NICE TA - Inotuzumab Ozogamicin for Treating Relapsed or Refractory B-Cell Acute Lymphoblastic Leukaemia

Published 09 August 2018Closed

Equality and Human Rights Consultation - NICE NG 102 - Community Pharmacies: Promoting Health and Wellbeing

Published 02 August 2018Closed

Equality and Human Rights Consultation - NICE TA - Pembrolizumab for Treating Relapsed or Refractory Classical Hodgkin Lymphoma

Published 25 July 2018Closed

Equality and Human Rights Consultation - NICE TA - Lenvatinib and Sorafenib for Treating Differentiated Thyroid Cancer After Radioactive Iodine

Published 20 July 2018Closed

Equality and Human Rights Consultation - NICE TA - Dinutuximab Beta for Treating High-Risk Neuroblastoma

Published 20 July 2018Closed

Equality and Human Rights Consultation - NICE TA - Lutetium (177lu) Oxodotreotide for Treating Unresectable or Metastatic Neuroendocrine Tumours

Published 20 July 2018Closed

Equality and Human Rights Consultation - NICE NG 101 - Early and Locally Advanced Breast Cancer: Diagnosis and Management

Published 18 July 2018Closed

Equality and Human Rights Consultation - NICE NG 99 - Brain Tumours (Primary) and Brain Metastases in Adults

Published 17 July 2018Closed

Equality and Human Rights Consultation - NICE NG 100 - Rheumatoid Arthritis in Adults: Management

Published 17 July 2018Closed

Equality and Human Rights Consultation - NICE TA - Alectinib for Untreated Anaplastic Lymphoma Kinase Positive Advanced Non-Small-Cell Lung Cancer

Published 16 July 2018Closed

Equality and Human Rights Consultation - NICE TA - Ixekizumab for Treating Active Psoriatic Arthritis After DMARDs

Published 16 July 2018Closed

Equality and Human Rights Consultation - NICE TA - Ocrelizumab for Treating Relapsing Multiple Sclerosis

Published 22 June 2018Closed

Equality and Human Rights Consultation - NICE TA - Dupilumab for Treating Moderate to Severe Atopic Dermatitis after Topical Treatments

Published 22 June 2018Closed

Equality and Human Rights Consultation - NICE NG 97 - Dementia: Assessment, Management and Support for People Living with Dementia and their Carers

Published 21 June 2018Closed

Equality and Human Rights Consultation - NICE NG 98 - Hearing Loss in Adults: Assessment and Management

Published 21 June 2018Closed

Equality and Human Rights Consultation - NICE TA - Cenegermin for Treating Neurotrophic Keratitis

Published 08 June 2018Closed

Equality and Human Rights Consultation - NICE TA - Pembrolizumab for Untreated PD-L1 Positive Metastatic Non-Small-Cell Lung Cancer (CDF Review of TA447)

Published 06 June 2018Closed

Equality and Human Rights Consultation - NICE TA - Beta Interferon and Glatiramer Acetate for Treating Multiple Sclerosis (Review of TA32)

Published 17 May 2018Closed

Equality and Human Rights Consultation - NICE TA - Atezolizumab for Treating Metastatic Urothelial Cancer after Platinum-Based Chemotherapy

Published 17 May 2018Closed

Pages

Back to top